Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
2seventy bio | 260 | 2023q3 | |||||||||
ACADIA Pharmaceuticals | 3,566 | 2023q1 | |||||||||
ADC Therapeutics | 121 | 2023q2 | |||||||||
ADMA Biologics | 1,421 | 2023q3 | |||||||||
ANI Pharmaceuticals | 1,422 | 2023q3 | |||||||||
ARCA biopharma | 26 | 2023q3 | |||||||||
AbCellera Biologics | 1,332 | 2023q3 | |||||||||
AbbVie | 315,227 | 2023 | |||||||||
Abeona Therapeutics | 131 | 2022 | |||||||||
Achilles Therapeutics | 52 | 2023q3 | |||||||||
Adaptive Biotechnologies | 621 | 2023q3 | |||||||||
Affimed | 596 | 2021 | |||||||||
Agilent Technologies | 43,601 | 2023q1 | |||||||||
Agios Pharmaceuticals | 1,652 | 2022 | |||||||||
Alector | 501 | 2023q2 | |||||||||
Allakos | 118 | 2023q3 | |||||||||
Allogene Therapeutics | 500 | 2023q3 | |||||||||
Alnylam Pharmaceuticals | 18,186 | 2022 | |||||||||
Amarin Corporation | 351 | 2023q2 | |||||||||
Amgen | 147,800 | 2023q3 |